Cargando…

Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital

PURPOSE: The study’s aim is to analyse the diagnostic performance of chest radiography (CXR) in patients with suspected coronavirus disease 19 (COVID-19). METHODS: We retrospectively considered 826 consecutive patients with suspected COVID-19 presenting to our emergency department (ED) from February...

Descripción completa

Detalles Bibliográficos
Autores principales: Flor, Nicola, Saggiante, Lorenzo, Savoldi, Anna Paola, Vitale, Renato, Casazza, Giovanni, Villa, Paolo, Brambilla, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254671/
https://www.ncbi.nlm.nih.gov/pubmed/34218365
http://dx.doi.org/10.1007/s10140-021-01946-x
_version_ 1783717776559439872
author Flor, Nicola
Saggiante, Lorenzo
Savoldi, Anna Paola
Vitale, Renato
Casazza, Giovanni
Villa, Paolo
Brambilla, Anna Maria
author_facet Flor, Nicola
Saggiante, Lorenzo
Savoldi, Anna Paola
Vitale, Renato
Casazza, Giovanni
Villa, Paolo
Brambilla, Anna Maria
author_sort Flor, Nicola
collection PubMed
description PURPOSE: The study’s aim is to analyse the diagnostic performance of chest radiography (CXR) in patients with suspected coronavirus disease 19 (COVID-19). METHODS: We retrospectively considered 826 consecutive patients with suspected COVID-19 presenting to our emergency department (ED) from February 21 to March 31, 2020, in a high disease prevalence setting. We enrolled patients who underwent CXR and rhino-oropharyngeal swab for real-time reverse transcription-polymerase chain reaction (rRT-PCR). CXRs were evaluated by an expert radiologist; a second independent analysis was performed by two residents in consensus. All readers, blinded to rRT-PCR results, classified CXRs positive/negative depending on presence/absence of typical findings of COVID-19, using rRT-PCR as reference standard. RESULTS: We finally analysed 680 patients (median age 58); 547 (80%) tested positive for COVID-19. The diagnostic performance of CXR, interpreted by the expert reader, was as follows: sensitivity (79.0%; 95% CI: 75.3–82.3), specificity (81.2%; 95% CI: 73.5–87.5), PPV (94.5%;95% CI: 92.0–96.4), NPV (48.4%; 95% CI: 41.7–55.2), and accuracy (79.3%; 95% CI: 76.0–82.2). For the residents: sensitivity (75.1%; 95% CI: 71.2–78.7), specificity (57.9%; 95% CI: 49.9–66.4), PPV (88.0%; 95% CI: 84.7–90.8), NPV (36.2%; 95% CI: 29.7–43.0), and accuracy (71.6%; 95% CI: 68.1–75.0). We found a significant difference between the reporting sensitivity (p = 0.013) and specificity (p < 0.0001) of expert radiologist vs residents. CXR sensitivity was higher in patients with symptom onset > 5 days before ED presentation compared to ≤ 5 days (84.4% vs 70.7%). CONCLUSIONS: CXR showed a sensitivity of 79% and a specificity of 81% in diagnosing viral pneumonia in symptomatic patients with clinical suspicion of COVID-19. Further studies in lower prevalence settings are needed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10140-021-01946-x.
format Online
Article
Text
id pubmed-8254671
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82546712021-07-06 Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital Flor, Nicola Saggiante, Lorenzo Savoldi, Anna Paola Vitale, Renato Casazza, Giovanni Villa, Paolo Brambilla, Anna Maria Emerg Radiol Original Article PURPOSE: The study’s aim is to analyse the diagnostic performance of chest radiography (CXR) in patients with suspected coronavirus disease 19 (COVID-19). METHODS: We retrospectively considered 826 consecutive patients with suspected COVID-19 presenting to our emergency department (ED) from February 21 to March 31, 2020, in a high disease prevalence setting. We enrolled patients who underwent CXR and rhino-oropharyngeal swab for real-time reverse transcription-polymerase chain reaction (rRT-PCR). CXRs were evaluated by an expert radiologist; a second independent analysis was performed by two residents in consensus. All readers, blinded to rRT-PCR results, classified CXRs positive/negative depending on presence/absence of typical findings of COVID-19, using rRT-PCR as reference standard. RESULTS: We finally analysed 680 patients (median age 58); 547 (80%) tested positive for COVID-19. The diagnostic performance of CXR, interpreted by the expert reader, was as follows: sensitivity (79.0%; 95% CI: 75.3–82.3), specificity (81.2%; 95% CI: 73.5–87.5), PPV (94.5%;95% CI: 92.0–96.4), NPV (48.4%; 95% CI: 41.7–55.2), and accuracy (79.3%; 95% CI: 76.0–82.2). For the residents: sensitivity (75.1%; 95% CI: 71.2–78.7), specificity (57.9%; 95% CI: 49.9–66.4), PPV (88.0%; 95% CI: 84.7–90.8), NPV (36.2%; 95% CI: 29.7–43.0), and accuracy (71.6%; 95% CI: 68.1–75.0). We found a significant difference between the reporting sensitivity (p = 0.013) and specificity (p < 0.0001) of expert radiologist vs residents. CXR sensitivity was higher in patients with symptom onset > 5 days before ED presentation compared to ≤ 5 days (84.4% vs 70.7%). CONCLUSIONS: CXR showed a sensitivity of 79% and a specificity of 81% in diagnosing viral pneumonia in symptomatic patients with clinical suspicion of COVID-19. Further studies in lower prevalence settings are needed. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10140-021-01946-x. Springer International Publishing 2021-07-03 2021 /pmc/articles/PMC8254671/ /pubmed/34218365 http://dx.doi.org/10.1007/s10140-021-01946-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Flor, Nicola
Saggiante, Lorenzo
Savoldi, Anna Paola
Vitale, Renato
Casazza, Giovanni
Villa, Paolo
Brambilla, Anna Maria
Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital
title Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital
title_full Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital
title_fullStr Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital
title_full_unstemmed Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital
title_short Diagnostic performance of chest radiography in high COVID-19 prevalence setting: experience from a European reference hospital
title_sort diagnostic performance of chest radiography in high covid-19 prevalence setting: experience from a european reference hospital
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254671/
https://www.ncbi.nlm.nih.gov/pubmed/34218365
http://dx.doi.org/10.1007/s10140-021-01946-x
work_keys_str_mv AT flornicola diagnosticperformanceofchestradiographyinhighcovid19prevalencesettingexperiencefromaeuropeanreferencehospital
AT saggiantelorenzo diagnosticperformanceofchestradiographyinhighcovid19prevalencesettingexperiencefromaeuropeanreferencehospital
AT savoldiannapaola diagnosticperformanceofchestradiographyinhighcovid19prevalencesettingexperiencefromaeuropeanreferencehospital
AT vitalerenato diagnosticperformanceofchestradiographyinhighcovid19prevalencesettingexperiencefromaeuropeanreferencehospital
AT casazzagiovanni diagnosticperformanceofchestradiographyinhighcovid19prevalencesettingexperiencefromaeuropeanreferencehospital
AT villapaolo diagnosticperformanceofchestradiographyinhighcovid19prevalencesettingexperiencefromaeuropeanreferencehospital
AT brambillaannamaria diagnosticperformanceofchestradiographyinhighcovid19prevalencesettingexperiencefromaeuropeanreferencehospital